Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

365.28 1.98 +0.55%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. 10-Q filed May 4, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed · accepted 2:10 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors: no material changes, the filing says; every paragraph is new since the annual report